(Q45036693)

8 December 2017

Resistant influenza A viruses in children treated with oseltamivir: descriptive study (English)

1 reference

8 December 2017

1 reference

3

Yuko Sakai-Tagawa

1 reference

8 December 2017

9

Yoshihiro Kawaoka

1 reference

8 December 2017

7

Frederick G Hayden

1 reference

8 December 2017

8

Norio Sugaya

1 reference

8 December 2017

Maki Kiso

1

1 reference

8 December 2017

Keiko Mitamura

2

1 reference

8 December 2017

Kyoko Shiraishi

4

1 reference

8 December 2017

Chiharu Kawakami

5

1 reference

8 December 2017

Kazuhiro Kimura

6

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

364

1 reference

8 December 2017

9436

1 reference

8 December 2017

759-765

1 reference

Perspectives on antiviral use during pandemic influenza

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Influenza virus neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Resistance of influenza viruses to neuraminidase inhibitors--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Position statement: global neuraminidase inhibitor susceptibility network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

In vivo Selection of an Influenza A2 Strain resistant to Amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Assessment of Development of Resistance to Antivirals in the Ferret Model of Influenza Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Oral oseltamivir treatment of influenza in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Plaque assay and primary isolation of influenza a viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916934-1

7 January 2021

10.1016/S0140-6736(04)16934-1

Identifiers

DOI

1 reference

8 December 2017

1 reference